UNSPSC 51422414: Halcinonide

This classification denotes a therapeutic glucocorticoid, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier SI86V6QNEG. European Medicines Agency schedules Halcinonide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07994MIG. Halcinonide generally arises in the molecular formula C24H32CLFO5.

UNSPSC 51422414 Halcinonide is a Commodity code that covers pharmaceutical products, but the recent state and local procurement activity tagged under it does not align with halcinonide specifically. Seminole County, Florida issued IFB60459723LAS in June 2026 seeking 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually—opioid-reversal medication and harm-reduction equipment, not corticosteroid creams. The solicitation indicates state and local buyers use this code family for emergency medical supplies and public health countermeasures, particularly naloxone procurement for community health initiatives, though the code's nominal scope is narrower.

Seminole County's procurement through its e-Procurement Portal (IFB, response deadline July 26, 2023) is the only recent opportunity the source identifies under this code. The contract calls for quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida, a two-year initial term with one-year renewal option, fixed-fee pricing, and E-Verify and drug-free workplace compliance. No explicit set-aside designations appear in the record. The source shows minimal recent activity under this code—a single Florida county opportunity dominates the visible record, suggesting either sparse procurement volume under the nominal halcinonide classification or systemic miscoding by the issuing body. Firms pursuing state and local pharmaceutical or emergency-supply contracts should verify the actual product specification before bid preparation, as the code label and actual buying behavior diverge.